Document Detail


Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea.
MedLine Citation:
PMID:  8866918     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. Theophylline is commonly used in neonatology for the treatment and prophylaxis of apnoea of prematurity, and during ventilator weaning. 2. NONMEM was used to study the population pharmacokinetics of intravenous and oral theophylline from retrospective drug monitoring data in 82 premature neonates, weighing < 1500 g at birth, and < or = 32 weeks gestational age. 3. Clearance (CL), volume of distribution (V), and oral bioavailability (F1) from liquid preparations were modelled alone, and under the influence of demographic and clinical covariates, assuming a 1-compartment model with first-order elimination. 4. The final population models with influential co-variates were as follows: CL (1h-1) = 0.0000123 *body weight (g) + 0.000377 *postnatal age (days); V (1) = 0.000937 *body weight (g); F = 0.918. 5. The CL was lower and V was higher than previously reported for less premature neonates, term babies, and older children. 6. Predictive performance of the population models was evaluated by Bayesian forecasting in a similar, but independent cohort of 30 infants. There was statistically insignificant bias and imprecision between measured and predicted serum theophylline concentrations. 7. Based on the validated population models, recommended maintenance theophylline dosages are provided for infants aged between 2 and 50 days, and weighing 700 to 2000 g.
Authors:
T C Lee; B G Charles; P A Steer; V J Flenady; T C Grant
Related Documents :
11432918 - The competence to acquire cellular desiccation tolerance is independent of seed morphol...
1453408 - Mefenamic acid in prevention of premature labour.
7686008 - Neurodevelopmental outcome of infants with apnea of infancy.
21381878 - Utility of performing routine head ultrasounds in preterm infants with gestational age ...
20864478 - Examination of faecal bifidobacterium populations in breast- and formula-fed infants du...
15262348 - Infectious and inflammatory mechanisms in preterm birth and cerebral palsy.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  41     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-12-13     Completed Date:  1996-12-13     Revised Date:  2009-10-02    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  191-200     Citation Subset:  IM    
Affiliation:
Department of Pharmacy, University of Queensland, Brisbane, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apnea / drug therapy*
Humans
Infant
Infant, Newborn
Retrospective Studies
Theophylline / pharmacokinetics*,  therapeutic use
Time Factors
Chemical
Reg. No./Substance:
58-55-9/Theophylline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes.
Next Document:  Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells.